VICO.ST Gross Margin

The Gross Margin of Vicore Pharma Holding AB (VICO.ST) is 197.14%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

VICO.ST Gross Margin - Historical Value

Date	Value
2024-12-31	197.14%
2023-12-31	197.14%

VICO.ST Gross Margin - Peers Comparison

Ticker	Name	Value
ALPHA.PA	Pharnext SA	-14187.50%
IVACC.ST	Intervacc AB	-29.92%
KAN.ST	Kancera AB	70.00%
VITR.ST	Vitrolife AB	59.27%
ACOU.ST	Acousort AB	-84.78%
ALONX.PA	Onxeo SA	64.38%
COX.PA	Nicox SA	100.00%
DNL.L	Diurnal Group PLC	78.16%
ERYP.PA	Erytech Pharma SA	7775.20%
BIOA B.ST	BioArctic AB	89.51%
BONEX.ST	Bonesupport Holding AB	92.60%
ECX.DE	Epigenomics AG	75.26%
PROB.ST	Probi AB	35.08%
B8F.DE	Biofrontera AG	80.64%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	78.03%
AEGIR.ST	Aegirbio AB	47.83%
BML.WA	Synthaverse SA	55.44%
HBC.OL	Hofseth Biocare ASA	34.13%
HNSA.ST	Hansa Biopharma AB	51.23%
TNG.PA	Transgene SA	-700.96%
ASIT.BR	DMS Imaging SA	25.00%
DEST.L	Destiny Pharma PLC	7775.20%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.23%
OASM.ST	Oasmia Pharmaceutical AB	-6845.60%
OKYO.L	OKYO Pharma Ltd	7775.20%
BONEH.HE	BBS-Bioactive Bone Substitutes Oyj	7775.20%
CYXO.ST	Cyxone AB	100.00%
OPTI.L	OptiBiotix Health PLC	49.69%
ADXN.SW	Addex Therapeutics Ltd	-958.33%
BIO.MC	Biosearch SA	39.64%
BIOG B.ST	Biogaia AB	72.45%
BIOPOR.CO	Bioporto A/S	67.68%
PA8.DE	Paion AG	94.10%
XBRANE.ST	Xbrane Biopharma AB	90.83%